(Circulation. 1997;95:2312-2317.)
© 1997 American Heart Association, Inc.
Articles |
From the Section on Cardiology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC 27157-1045.
Correspondence to Pieter P. de Tombe, PhD, Department of Physiology and Biophysics, College of Medicine, University of Illinois at Chicago, 900 S Ashland Ave, Chicago, IL 60607-7171. E-mail PDETOMBE{at}UIC.EDU
| Abstract |
|---|
|
|
|---|
Methods and Results Contractile force, tension, and calcium responsiveness were measured in single-skinned myocytes isolated from rats with right ventricular hypertrophy (RVH) and control rats. RVH was induced by pulmonary artery constriction for 36 weeks and was associated with significant myocyte hypertrophy. Myocytes were attached to micropipettes that extended from a force transducer and motor. Isometric force was measured over a wide range of calcium concentrations at two sarcomere lengths (SLs). Maximal force was increased in the RVH group: 1.20±0.10 versus 1.62±0.13 mg at SL=2.0 µm and 1.33±0.10 versus 1.84±0.15 mg at SL=2.3 µm (P<.05). Maximal tension, however, was reduced in the RVH group: 24.3±1.91 versus 37.5±2.92 mN/mm2 at SL=2.0 µm and 27.4±1.78 versus 41.8±3.19 mN/mm2 at SL=2.3 µm (P<.01). The concentration of calcium ions required for half-maximal activation was increased in the RVH group: 2.64±0.13 versus 3.47±0.22 µmol/L at SL=2.0 µm and 2.23±0.15 versus 2.86±0.18 µmol/L at SL=2.3 µm (P<.01). The slope of the force-calcium relationship (Hill coefficient) was decreased in the RVH group at SL=2.0 µm (4.3±0.4 versus 3.1±0.2, P=.04) but not at SL=2.3 µm (3.8±0.2 versus 3.6±0.2, P=NS).
Conclusions These results suggest that the depressed cardiac function of end-stage myocardial hypertrophy may be due, in part, to altered contractile protein function.
Key Words: heart failure hypertrophy contractility proteins calcium
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
Myocyte Isolation
Single isolated myocytes were obtained by using an enzymatic
retroperfusion technique.12 In brief, rats were deeply
anesthetized with halothane by inhalation to effect, and the
heart was rapidly removed. The aorta was then cannulated and
immediately connected to a Langendorff retroperfusion system. Next, the
heart was perfused for 5 minutes with a Ringer's solution (see
"Solutions" below) that contained 1.0 mmol/L
Ca2+ to allow for the washout of blood from the
coronary circulation. After this the heart was perfused for 4
minutes with a similar solution but without added Ca2+
(nominally calcium-free Ringer's solution). This perfusion was
followed by 22 minutes of perfusion with an enzymatic Ringer's
solution containing 0.8 mg/mL class I collagenase
(Whorthington), 0.38 mg/mL hyaluronidase (Sigma), and 50 µmol/L
added Ca2+. Upon completion of this perfusion, the
free wall of the RV was dissected from the heart. To ensure that only
RV myocytes were obtained and that no part of the left ventricle or the
intraventricular septum was included, only the
center portion of the RV free wall was dissected. The RV free wall was
minced and gently agitated in the enzymatic Ringer's solution to which
1 mg/mL BSA had been added. Debris were removed by filtering the
processed RV free wall through a 300-µm nylon mesh. Cells were then
allowed to precipitate by gravitation, and the supernatant was
discarded. The cells were resuspended in enzyme-free Ringer's solution
with 50 µmol/L added Ca2+. The cells were then
washed two additional times with a Ringer's solution by using this
procedure; the first solution contained 0.5 mmol/L added
Ca2+, and the second had 1.0 mmol/L added
Ca2+. Rod-shaped cells that were obtained via this
procedure were "calcium-tolerant," intact cells. For the purpose
of measuring force, cells were next sedimented and then resuspended in
a skinning solution for 6 minutes to chemically
permeabilize the myocytes. The skinning solution was
composed of standard relaxing solution (see "Solutions" below) to
which 1% ultrapure Triton-X100 (Pierce) had been added. Finally, the
skinned myocytes were washed twice in relaxing solution to remove the
Triton-X100 and stored on ice for <12 hours before data
collection.
Experimental Setup and Cell Attachment
Experiments were performed on the stage of an inverted
microscope (Olympus). Single myocytes were attached at either end to
glass micropipettes with silicone glue (Dow Corning).12 13 14
The stage was modified to allow for temperature control of the
superfusate (16±0.2°C) and contained several solution wells
into which the attached cell could rapidly be moved to expose the
myocyte to solutions containing different concentrations of free
calcium ions.15 Fig 1
shows an example of
an attached cell. One pipette was mounted on a sensitive force
transducer (Cambridge model 403A;
300 Hz resonant frequency), and
the other pipette was attached to a high-speed motor (Cambridge model
308;
1-msec 90% step response). Both pipettes were connected to
X-Y-Z manipulators (Newport). Cell length was adjusted by using the
motor, which was controlled via computer (Apple PPC 100 mHz) using
custom-designed software (Labview, National Instruments). FD and cell
length were also recorded by computer for off-line
analysis. Developed force was measured during each activating
cycle; the zero force level was identified by instituting a quick ramp
shortening in cell length just before moving the cell back to the
relaxing solution (pCa=9.0). Fig 2A
shows a series of
such quick length-release steps recorded at varying levels of
activation for a single myocyte.
|
|
SL Measurement
The attached cell was monitored by video microscopy using a x40
Hoffman Modulation Contrast objective, a x10 video adapter tube, and a
gray-scale video camera. The image was displayed on a video monitor and
sampled via computer for on-line analysis of SL using
custom-designed software (Labview) as follows. A region of the image
that encompassed most of the attached myocyte was selected, and each
horizontal pixel line was transformed by fast Fourier transformation
into the spatial frequency domain. The amplitude spectra were averaged,
and the peak power of the first-order harmonic in the spatial frequency
domain was detected (see Fig 1D
and 1E
). This value was then converted
into a median SL across the region. The system was calibrated with
glass gratings of known spacing; the resolution of the system was
10
nm, and acquisition speed was
0.5 seconds.
Measurement of Cross-sectional Area
To compare tension generation between cells of different sizes,
we normalized total force to myocyte cross-sectional area measured
while the cell was placed in relaxing solution at SL=2.0 µm.
Cell width was measured directly from the vertical projection of
the cell on the video image. Cell thickness was measured from a
horizontal projection of the cell from a 45° mirror that was
mounted on a hydraulic manipulator (Newport) positioned next to the
cell (see Fig 1C
). Cross-sectional area was calculated by assuming that
the cell had a rectangular shape. Tension development, calculated as
force normalized to cross-sectional area, is expressed as
mN/mm2.
Solutions
The perfusate used for cell isolation was a modified
Ringer's solution of the following composition (in mmol/L):
Na+ 125, K+ 6.8,
Cl- 125.2, Mg2+ 1.2,
H2PO4- 2,
d-glucose 11, insulin 1.0, and Ca2+ as indicated. pH
was adjusted to 7.4 by adding NaOH. For some steps in the cell
isolation, collagenase and hyaluronidase were added as
solids to this solution.
For skinned single myocytes, relaxing and activating solutions were
used; the compositions of these solutions (Table 1
) were
calculated by using the methods described by Fabiato and
Fabiato.16 We have observed a rather high variability in
the force-calcium relation of isolated myocardium when
solutions were prepared or mixed each day during the ongoing
experiment. We sought to reduce this solution-induced variability in
the force-calcium relation to allow for a more accurate comparison
between the experimental groups. To this end, solutions of varying free
calcium concentrations were prepared, and aliquots were stored at
-30°C until used for each individual myocyte. All chemicals were of
the highest purity available (Sigma Chemical Co).
|
Protocol and Data Analysis
The responsiveness of the contractile proteins to calcium ions,
ie, the force-calcium relation, was determined as follows. SL was
initially set at 2.3 µm. After two or three exposures of the
myocyte to the activation solution (ie, maximum activation), SL was
readjusted to 2.3 µm. The purpose of the preexposure to
activating solution was to allow the cell to set into the silicone glue
attachments. Isometric force during maximum activation was measured at
the beginning, middle, and end of the experiment to assess rundown of
the preparation; the cell was not included in the final data
analysis if force declined by >10% in a successive test
contraction at the maximum activation. The average rundown was
7.8±1.7% in the control group and 5.9±1.2% in the RVH group (n=28,
P=.4). We consistently observed clear striations and
sarcomere registration at activation levels up to close to maximum
activation in individual myocytes (
80% FD; see Figs 1
and 2
). In
addition to force rundown, the cell was also discarded if SL shortened
by >10% at that level of activation. In between the test
contractions, FD was measured at varying submaximal free calcium
concentrations. FD was corrected for rundown by assuming that each
contraction between the test contractions at maximum activation
contributed equally to the force rundown. The relation between free
calcium and FD resembled a sigmoidal function, and the data were fit to
a modified Hill equation (Fig 2
)
![]() |
It has been reported that the response of isolated cardiac muscle to a change in SL, ie, the Frank-Starling mechanism, is diminished in human heart failure.17 To examine the response of FD to changes in SL in the setting of RVH, we determined the force-calcium relation at both a high (2.3 µm) and low (2.0 µm) SL. These lengths of the cardiac sarcomere encompass most of the working range in in situ hearts.18
A two-tailed unpaired Student's t test was used to test for significant differences between group means, ie, between control and RVH animals. Thus, the fit parameters that resulted from the nonlinear fit to the Hill equation were treated statistically as if they were obtained by direct measurement. Statistical analyses were performed by using commercially available software (SYSTAT). Data are presented as mean±SEM; a probability value of <.05 was considered significant.
| Results |
|---|
|
|
|---|
Contractile Force
Seven myocytes from 6 control rats and seven myocytes from 5 RVH
rats were included for force measurement. Table 2
shows
the average values of maximum force, MT, EC50, and
Hill coefficient that were obtained at the high and low SL in each
individual myocyte. The average tension-calcium relation derived from
the group data is shown in Fig 3
. In addition, Table 2
shows the average cell width, thickness, and cross-sectional area that
were obtained at the low SL. Tension in myocytes obtained from control
animals at the high SL amounted to
42 mN/mm2. This
value is comparable to the MT value of 37 mN/mm2
reported by Strang et al12 for single rat cardiac
myocytes, and it is also within the range of MT values for isolated rat
cardiac trabeculae.7 20 Values for passive
tension of myocytes obtained from control animals were 0.9±0.04 and
2.5±0.15 mN/mm2 at SL=2.0 and 2.3 µm,
respectively. These values are similar to the passive tension values
reported for both intact isolated rat cardiac myocytes21
and trabeculae.7 Passive tension was slightly
but significantly (P<.05) lower at both SLs in the RVH group
(0.6±0.04 and 1.4±0.07 mN/mm2 at SL=2.0 and 2.3
µm, respectively).
|
|
FD at maximum activation as well as cross-sectional area were
significantly (P<.05 for both) increased in the RVH group
(Table 2
). However, because cross-sectional area increased out of
proportion to FD, MT was significantly decreased in the RVH group.
Thus, RVH was associated with 34% and 35% decreases in MT development
at SL=2.3 and 2.0 µm, respectively (P<.01). In
addition, the calcium sensitivity index (EC50)
was significantly (P<.05) increased by 28% and 31%,
respectively, at SL=2.3 and 2.0 µm. Thus, RVH was also
associated with a significant decrease in calcium responsiveness of the
single isolated cardiac myocytes. Finally, the slope of the tension-pCa
relation, as indexed by the Hill coefficient, was significantly reduced
in the RVH group at SL=2.0 but not 2.3 µm. The average value of
the Hill coefficient in the control group is comparable to values found
by investigators using skinned single isolated rat
myocytes.22 23 This result implies that RVH is associated
with a reduction in the level of cooperative FD at the lower but not at
the higher SL.
The average difference between the EC50 obtained at the high and low SLs in each individual myocyte amounted to 0.4±0.07 and 0.6±0.10 µmol/L in the control and RVH groups, respectively (P=.13). These values are comparable to that obtained by McDonald et al14 in rat cardiac myocytes. This result indicates that the effect of a change in SL on the calcium responsiveness of the contractile apparatus, ie, the Frank-Starling mechanism, was not affected by RVH.
| Discussion |
|---|
|
|
|---|
A number of investigators3 4 5 7 employing multicellular
isolated muscle preparations have reported a decrease in active tension
development in RVH. However, interpretation of those studies may be
limited since MH is accompanied by a significant increase in the
content of extracellular matrix proteins.4 8 9 Therefore,
the reduction in tension development may be due merely to a reduction
in the number of force-generating elements per cross-sectional area of
myocardium, without an actual change in intrinsic
contractile protein function. The results of the present study show
that although maximally activated force
(Fmax) was significantly increased in RVH,
tension was significantly decreased at the cellular level (Table 2
and
Fig 3
). The average decrease in active tension reported in intact,
multicellular preparations in MH amounts to
55%3 4 5 ; in
the present study we found an
35% reduction in tension at the
cellular level. Because the myocyte isolation procedure effectively
removes the extracellular collagen matrix proteins, these results
indicate that part of the reduced tension development in RVH has at its
base an alteration in tension development at the level of the cardiac
cell. The mechanism underlying the decrease of MT development of
myocytes is presently unknown, but may be due either to a reduced
availability of myofilaments in the cardiac cell or to a decreased
efficiency of myofilaments to generate force.
The notion of altered myofilament function is further supported by the decrease in calcium responsiveness that was observed in the present study. This finding conflicts with reports that have indicated no changes in calcium responsiveness in RVH.5 25 The reasons for this discrepancy are not entirely clear, but may be related to the fact that other studies have investigated stable myocardial hypertrophy, while in the present model hypertrophy had progressed to heart failure.24 Furthermore, we eliminated the variation in the force-calcium relation between cells that is induced by variations in the "skinned fiber" solutions (see "Methods"). The mechanisms underlying the decrease in calcium responsiveness with MH are not clear. We have shown7 that a shift of isomyosin in itself does not affect the force-calcium relation in rat myocardium. Hence, it is unlikely that an alteration in isomyosin synthesis could cause the reduced maximally activated FD and decreased calcium responsiveness sensitivity. It has been reported that human dilated cardiomyopathy is associated with an alteration in troponin T isoform expression26 and reduced myocardial content of myosin light chain 2.27 Hence, these abnormalities in contractile protein components could potentially be responsible for the altered calcium responsiveness of the cardiac sarcomere.28 Whether such changes in contractile protein composition occur in RVH cannot be determined from the present study. Regardless of the underlying mechanism, however, decreased MT development and calcium responsiveness would explain, in part, the reduction in myocardial contractile function observed in decompensated MH. We cannot exclude the possibility, however, that other factors, such as an alteration in myocyte calcium handling5 29 or matrix change8 24 may also play a role. Wolff et al13 report an increased calcium responsiveness of permeabilized canine myocytes in chronic pacing-induced heart failure, which is in contrast to the present findings. The reason for this discrepancy is unclear, but may be related to differences in the experimental models, ie, pacing-induced canine heart failure versus rat RVH.
Schwinger et al17 report that the effect of changes in SL on myofibrillar calcium sensitivity is attenuated in human heart failure. Our results do not support this conclusion, since the effect of changes in SL on the calcium sensitivity index (EC50) was preserved in RVH. The differences in our findings may be related to differences in the pathophysiology of dilated cardiomyopathy versus pressure overload hypertrophy, species difference, and differences in the methodological approaches, ie, isolated myocytes versus papillary muscle preparations. Our findings suggest that any structural contractile protein abnormalities in ventricular hypertrophy spare the moieties responsible for modulation of length-dependent activation but affect those that modulate overall calcium sensitivity and MT generation.
Several experimental limitations need to be considered. First, the
level of contractile protein phosphorylation of the
skinned myocytes may be different from the in situ condition.
Therefore, it is not possible to directly extrapolate the findings of
the present study to contractile function of myocardium
under physiological conditions. Second, sarcomere
shortening during activation can potentially arise due to the cell
attachment method that was employed in the present
study.12 14 22 23 As a result, SL may have varied at
different levels of contractile activation. Myocytes in which excessive
sarcomere shortening occurred were excluded from the present study,
and although we attempted to minimize the effect of uncontrolled
sarcomere shortening (see "Methods"), it could not altogether be
avoided. Likewise, it should be noted that some inhomogeneity in SL may
have been present in the cells. The measured values for SL in
relaxing solution were averages obtained from most of the cell between
the attachment sites. Nevertheless, these factors should not affect the
major conclusion of the present study, since myocytes from both the
control and RVH groups were affected equally. Third, some of the cells
that were included in the present study were derived from the same
animal (one heart in the control group provided two cells; two hearts
in the RVH group provided two cells). To assess the effect of this
potential confounding factor, we averaged the data from those pairs of
cells to obtain single measurement values. Analyses of this
data set (control n=6, RVH n=5), however, resulted in similar average
results and, furthermore, did not alter the statistical outcome of the
study. Finally, tension development was calculated as force per
cross-sectional area assuming a rectangular shape of the cell in both
groups. However, a change in cell geometry in RVH would affect the
calculation of tension. To assess the possible effect of this
variable, we recalculated tension development in the RVH group
based on an ellipsoid shape. This maximum possible change in geometry
reduced the difference in MT between the groups to
25%
(P=.1). Nevertheless, since this is the extreme of the
possible shape change between the two groups, we do not consider it
likely that this factor alone would be responsible for the observed
changes.
In conclusion, in the present study we investigated the effect of MH on myofibrillar contractile function in rat myocardium. MH was associated with a marked depression of maximally activated tension development and a reduction in calcium responsiveness. These results suggest that diminished contractile function in MH is due, in part, to an alteration in contractile protein function.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received October 10, 1996; revision received December 2, 1996; accepted December 9, 1996.
| References |
|---|
|
|
|---|
2. Meerson FZ. The myocardium in hyperfunction, hypertrophy, and heart failure. Circ Res. 1969;25(suppl II):II-1-II-163.
3.
Spann JF, Buccino RA, Sonnenblick EH, Braunwald
E. Contractile state of cardiac muscle obtained from cats with
experimentally produced ventricular hypertrophy
and heart failure. Circ Res. 1967;21:341-354.
4. Cooper G, Tomanek RJ, Ehrhardt JC, Marcus ML. Chronic progressive pressure overload of the cat right ventricle. Circ Res. 1981;48:488-497.[Abstract]
5.
Gwathmey JK, Morgan JP. Altered calcium
handling in experimental pressure-overload hypertrophy in
the ferret. Circ Res. 1985;57:836-843.
6. Baudet S, Kutznetsov A, Merciai N, Gorza L, Ventura-Clapier R. Biochemical, mechanical and energetic characterization of right ventricular hypertrophy in the ferret heart. J Mol Cell Cardiol. 1994;26:1573-1586.[Medline] [Order article via Infotrieve]
7. de Tombe PP, Wannenburg T, Fan DS, Little WC. Right ventricular contractile protein function in rats with left ventricular myocardial infarction. Am J Physiol Heart Circ Physiol. 1996;271:1173-11791996;271:1173-1179.
8. Weber KT. Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol. 1989;13:1637-1652.[Abstract]
9.
Litwin SE, Litwin CM, Raya TE, Warner AL, Goldman
S. Contractility and stiffness of noninfarcted
myocardium after coronary ligation in rats: effects
of chronic angiotensin converting enzyme inhibition.
Circulation. 1991;83:1028-1037.
10. Schouten VJA, Vliegen HW, Van der Laarse A, Huysmans HA. Altered calcium handling at normal contractility in hypertrophied rat heart. J Mol Cell Cardiol. 1990;22:987-998.[Medline] [Order article via Infotrieve]
11.
Spann JF, Chidsey CA, Pool PE, Braunwald E.
Mechanisms of norepinephrine depletion in experimental
heart failure produced by aortic constriction in the guinea pig.
Circ Res. 1965;17:312-321.
12.
Strang KT, Sweitzer NK, Greaser ML, Moss RL.
ß-Adrenergic receptor stimulation increases unloaded shortening
velocity of skinned single ventricular myocytes from rats.
Circ Res. 1994;74:542-549.
13.
Wolff MR, Whitesell LF, Moss RL. Calcium
sensitivity of isometric tension is increased in canine experimental
heart failure. Circ Res. 1995;76:781-789.
14.
McDonald KS, Field LJ, Parmacek MS, Soonpaa M, Leiden
JM, Moss RL. Length dependence of Ca2+ sensitivity of tension in
mouse cardiac myocytes expressing skeletal troponin C. J
Physiol. 1995;483:131-139.
15.
Sweitzer NK, Moss RL. Determinants of loaded
shortening velocity in single cardiac myocytes
permeabilized with
-hemolysin. Circ Res. 1993;73:1150-1162.
16. Fabiato A, Fabiato F. Computer programs for calculating total from specified free or free from specified total ionic concentrations in aqueous solutions containing multiple metals and ligands. J Physiol Paris. 1979;75:463-505.[Medline] [Order article via Infotrieve]
17.
Schwinger RHG, Böhm M, Koch A, Schmidt U, Morano
I, Eissner H-J, Überfuhr P, Reichart B, Erdmann E. The
failing human heart is unable to use the Frank-Starling mechanism.
Circ Res. 1994;74:959-969.
18.
Rodriguez EK, Hunter WC, Royce MJ, Leppo MK, Douglas
AS, Weisman HF. A method to reconstruct myocardial sarcomere
lengths and orientations at transmural sites in beating canine hearts.
Am J Physiol Heart Circ Physiol. 1992;263:H293-H306.
19.
Fraticelli A, Josephson R, Danziger R, Lakatta E,
Spurgeon HA. Morphological and contractile characteristics of
rat cardiac myocytes from maturation to senescence. Am J
Physiol Heart Circ Physiol. 1989;257:H259-H265.
20.
ter Keurs HEDJ, Rijnsburger WH, van Heuningen R,
Nagelsmit MJ. Tension development and sarcomere length in rat
cardiac trabeculae: evidence of length-dependent
activation. Circ Res. 1980;46:703-714.
21.
Roos KP, Brady AJ. Stiffness and shortening
changes in myofilament-extracted rat cardiac myocytes. Am J
Physiol. 1989;256:H539-H551.
22.
Hofmann PA, Lange JH III. Effects of
phosphorylation of troponin I and C protein on
isometric tension and velocity of unloaded shortening in skinned single
cardiac myocytes from rats. Circ Res. 1994;74:718-726.
23.
McDonald KS, Moss RL. Osmotic compression of
single cardiac myocytes eliminates the reduction in
Ca2+ sensitivity of tension at short sarcomere
length. Circ Res. 1995;77:199-205.
24.
Boluyt MO, O'Neill L, Meredith AL, Bing OHL, Brooks
WW, Conrad CH, Crow MT, Lakatta EG. Alterations in cardiac gene
expression during the transition from stable hypertrophy to
heart failure: marked upregulation of genes encoding extracellular
matrix components. Circ Res. 1994;75:23-32.
25.
Perreault CL, Shannon RP, Shen Y-T, Vatner SF, Morgan
JP. Excitation-contraction coupling in isolated
myocardium from dogs with compensated left
ventricular hypertrophy. Am J
Physiol Heart Circ Physiol. 1994;266:H2436-H2442.
26.
Anderson PAW, Malouf NN, Oakeley AE, Pagani ED, Allen
PD. Troponin-T isoform expression in humans: a comparison among
normal and failing adult heart, fetal heart, and adult and fetal
skeletal muscle. Circ Res. 1991;69:1226-1233.
27.
Margossian SS, White HD, Caulfield JB, Norton P, Taylor
S, Slayter HS. Light chain 2 profile and activity of human
ventricular myosin during dilated
cardiomyopathy: identification of a causal agent
for impaired myocardial function. Circulation. 1992;85:1720-1733.
28.
Solaro RJ. Myosin and why hearts fail.
Circulation. 1992;85:1945-1947.
29.
Siri FM, Krueger J, Nordin C, Ming Z, Aronson
RS. Depressed intracellular calcium transients and contraction
in myocytes from hypertrophied and failing guinea pig hearts.
Am J Physiol Heart Circ Physiol. 1991;261:H514-H530.
This article has been cited by other articles:
![]() |
T. Bupha-Intr, K. M. Haizlip, and P. M. L. Janssen Temporal changes in expression of connexin 43 after load-induced hypertrophy in vitro Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H806 - H814. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Colson, T. Bekyarova, M. R. Locher, D. P. Fitzsimons, T. C. Irving, and R. L. Moss Protein Kinase A-Mediated Phosphorylation of cMyBP-C Increases Proximity of Myosin Heads to Actin in Resting Myocardium Circ. Res., August 1, 2008; 103(3): 244 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hamdani, V. Kooij, S. van Dijk, D. Merkus, W. J. Paulus, C. d. Remedios, D. J. Duncker, G. J.M. Stienen, and J. van der Velden Sarcomeric dysfunction in heart failure Cardiovasc Res, March 1, 2008; 77(4): 649 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Belin, M. P. Sumandea, E. J. Allen, K. Schoenfelt, H. Wang, R. J. Solaro, and P. P. de Tombe Augmented Protein Kinase C-{alpha}-Induced Myofilament Protein Phosphorylation Contributes to Myofilament Dysfunction in Experimental Congestive Heart Failure Circ. Res., July 20, 2007; 101(2): 195 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. F. Edes, D. Czuriga, G. Csanyi, S. Chlopicki, F. A. Recchia, A. Borbely, Z. Galajda, I. Edes, J. van der Velden, G. J. M. Stienen, et al. Rate of tension redevelopment is not modulated by sarcomere length in permeabilized human, murine, and porcine cardiomyocytes Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R20 - R29. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. G. Daniels, T. Naya, V. L. M. Rundell, and P. P. de Tombe Development of contractile dysfunction in rat heart failure: hierarchy of cellular events Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R284 - R292. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Belin, M. P. Sumandea, T. Kobayashi, L. A. Walker, V. L. Rundell, D. Urboniene, M. Yuzhakova, S. H. Ruch, D. L. Geenen, R. J. Solaro, et al. Left ventricular myofilament dysfunction in rat experimental hypertrophy and congestive heart failure Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2344 - H2353. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Jweied, R. D. McKinney, L. A. Walker, I. Brodsky, A. S. Geha, M. G. Massad, P. M. Buttrick, and P. P. de Tombe Depressed cardiac myofilament function in human diabetes mellitus Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2478 - H2483. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Borbely, A. Toth, I. Edes, L. Virag, J. G. Papp, A. Varro, W. J. Paulus, J. van der Velden, G. J.M. Stienen, and Z. Papp Peroxynitrite-induced {alpha}-actinin nitration and contractile alterations in isolated human myocardial cells Cardiovasc Res, August 1, 2005; 67(2): 225 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Gillis, B. Liang, F. Chung, and G. F. Tibbits Increasing mammalian cardiomyocyte contractility with residues identified in trout troponin C Physiol Genomics, June 16, 2005; 22(1): 1 - 7. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Versluis, J. W. Heslinga, P. Sipkema, and N. Westerhof Contractile reserve but not tension is reduced in monocrotaline-induced right ventricular hypertrophy Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H979 - H984. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ke, L. Wang, W. G. Pyle, P. P. de Tombe, and R. J. Solaro Intracellular Localization and Functional Effects of P21-Activated Kinase-1 (Pak1) in Cardiac Myocytes Circ. Res., February 6, 2004; 94(2): 194 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kogler, O. Hartmann, K. Leineweber, P. Nguyen van, P. Schott, O.-E. Brodde, and G. Hasenfuss Mechanical Load-Dependent Regulation of Gene Expression in Monocrotaline-Induced Right Ventricular Hypertrophy in the Rat Circ. Res., August 8, 2003; 93(3): 230 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P Konhilas, T. C Irving, B. M Wolska, E. E Jweied, A. F Martin, R John Solaro, and P. P de Tombe Troponin I in the murine myocardium: influence on length-dependent activation and interfilament spacing J. Physiol., March 15, 2003; 547(3): 951 - 961. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Papp, A. Szabo, J. P. Barends, and G J M Stienen The mechanism of the force enhancement by MgADP under simulated ischaemic conditions in rat cardiac myocytes J. Physiol., August 15, 2002; 543(1): 177 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. van der Velden, L.J. Klein, R. Zaremba, N.M. Boontje, M.A.J.M. Huybregts, W. Stooker, L. Eijsman, J.W. de Jong, C.A. Visser, F.C. Visser, et al. Effects of Calcium, Inorganic Phosphate, and pH on Isometric Force in Single Skinned Cardiomyocytes From Donor and Failing Human Hearts Circulation, September 4, 2001; 104(10): 1140 - 1146. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Suematsu, S. Satoh, S. Kinugawa, H. Tsutsui, S. Hayashidani, R. Nakamura, K. Egashira, N. Makino, and A. Takeshita {alpha}1-Adrenoceptor-Gq-RhoA signaling is upregulated to increase myofibrillar Ca2+ sensitivity in failing hearts Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H637 - H646. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Irving, J. Konhilas, D. Perry, R. Fischetti, and P. P. de Tombe Myofilament lattice spacing as a function of sarcomere length in isolated rat myocardium Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2568 - H2573. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. van der Velden, J.W. de Jong, V.J. Owen, P.B.J. Burton, and G.J.M. Stienen Effect of protein kinase A on calcium sensitivity of force and its sarcomere length dependence in human cardiomyocytes Cardiovasc Res, June 1, 2000; 46(3): 487 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Papp, J. van der Velden, and G.J.M Stienen Calpain-I induced alterations in the cytoskeletal structure and impaired mechanical properties of single myocytes of rat heart Cardiovasc Res, March 1, 2000; 45(4): 981 - 993. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. E. G. Ekelund, R. W. Harrison, O. Shokek, R. N. Thakkar, R. S. Tunin, H. Senzaki, D. A. Kass, E. Marban, and J. M. Hare Intravenous Allopurinol Decreases Myocardial Oxygen Consumption and Increases Mechanical Efficiency in Dogs With Pacing-Induced Heart Failure Circ. Res., September 3, 1999; 85(5): 437 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
J van der Velden, L.J Klein, M van der Bijl, M.A.J.M Huybregts, W Stooker, J Witkop, L Eijsman, C.A Visser, F.C Visser, and G.J.M Stienen Isometric tension development and its calcium sensitivity in skinned myocyte-sized preparations from different regions of the human heart Cardiovasc Res, June 1, 1999; 42(3): 706 - 719. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Perez, K. Hashimoto, S. McCune, R. A. Altschuld, and E. Marban Origin of Contractile Dysfunction in Heart Failure : Calcium Cycling Versus Myofilaments Circulation, March 2, 1999; 99(8): 1077 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
J van der Velden, L.J Klein, M van der Bijl, M.A.J.M Huybregts, W Stooker, J Witkop, L Eijsman, C.A Visser, F.C Visser, and G.J.M Stienen Force production in mechanically isolated cardiac myocytes from human ventricular muscle tissue Cardiovasc Res, May 1, 1998; 38(2): 414 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P de Tombe Altered contractile function in heart failure Cardiovasc Res, February 1, 1998; 37(2): 367 - 380. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Dobesh, J. P. Konhilas, and P. P. de Tombe Cooperative activation in cardiac muscle: impact of sarcomere length Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H1055 - H1062. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Cazorla, Y. Wu, T. C. Irving, and H. Granzier Titin-Based Modulation of Calcium Sensitivity of Active Tension in Mouse Skinned Cardiac Myocytes Circ. Res., May 25, 2001; 88(10): 1028 - 1035. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |